The Petri Dish: Longwood Fund unveils $38M gene therapy startup


Carbon Biosciences aims to use novel parvovirus vectors that can deliver larger gene therapy payloads more safely.

Previous Orange Grove Bio taps world-renowned biopharma leader for new role
Next Phoenix group behind Restaurant Progress looks to expand